Bell Investment Advisors’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $732 | Buy |
65
+58
| +829% | +$653 | ﹤0.01% | 1679 |
|
2025
Q1 | $40 | Hold |
7
| – | – | ﹤0.01% | 1894 |
|
2024
Q4 | $69 | Hold |
7
| – | – | ﹤0.01% | 1890 |
|
2024
Q3 | $58 | Sell |
7
-1
| -13% | -$8 | ﹤0.01% | 1871 |
|
2024
Q2 | $106 | Hold |
8
| – | – | ﹤0.01% | 1931 |
|
2024
Q1 | $367 | Sell |
8
-10
| -56% | -$459 | ﹤0.01% | 1876 |
|
2023
Q4 | $1.21K | Sell |
18
-51
| -74% | -$3.41K | ﹤0.01% | 1531 |
|
2023
Q3 | $5.01K | Sell |
69
-3
| -4% | -$218 | ﹤0.01% | 803 |
|
2023
Q2 | $5.38K | Buy |
72
+1
| +1% | +$75 | ﹤0.01% | 784 |
|
2023
Q1 | $3.77K | Sell |
71
-7
| -9% | -$372 | ﹤0.01% | 924 |
|
2022
Q4 | $5.26K | Buy |
78
+25
| +47% | +$1.69K | ﹤0.01% | 782 |
|
2022
Q3 | $7K | Buy |
53
+31
| +141% | +$4.09K | ﹤0.01% | 529 |
|
2022
Q2 | $2K | Buy |
+22
| New | +$2K | ﹤0.01% | 1126 |
|